Αποτελέσματα Αναζήτησης
Pfizer and BioNTech conclude Phase 3 study of COVID-19 vaccine candidate, meeting all primary efficacy endpoints. Published November 18, 2020. Accessed October 27, 2021. https://www.pfizer.com/ news/press-release/press-release-detail/pfizer-and-biontech-conclude-phase-3-study-covid-19-vaccine. Pfizer.
3 Μαΐ 2022 · A timeline of critical events in the COVID-19 vaccine development progress. WHO has approved the emergency use of ten vaccines (including three India vaccines, COVISHIELD, COVAXIN, and...
21 Ιουλ 2020 · Various phases of vaccine development are: Preclinical trials are done in suitable animals for safely and efficacy by challenge studies. Clinical Studies are made in 4 phases:
11 Σεπ 2023 · The goal of this study was to compare the research and development (R&D), launch and scale up timelines of COVID-19 and non-COVID-19 vaccines and derive key lessons learnt from the COVID-19 pandemic and their implications for the development, launch and scale up of vaccines for other diseases.
9 Απρ 2021 · The development of several highly efficacious vaccines against a previously unknown viral pathogen, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in less than 1 year from the identification of the virus is unprecedented in the history of vaccinology.
measures such as mix-and-match vaccination, developing new vaccines like nanoparticle vaccines, and optimizing immune adjuvant to improve vaccine safety and efficacy could be considered.
“Why so fast?” “Are corners being cut?” “Is the vaccine safe?” These are the questions that we have heard almost every day since COVID-19 vaccine development began in January 2020 in response to the pandemic that has ravaged the world.
